| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 26,928,000 | 13,074,000 | 13,643,000 | 12,920,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 26,928,000 | 13,074,000 | 13,643,000 | 12,920,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (6,797,000) | 11,253,000 | (1,038,000) | 2,192,000 | | Non Recurring |
-
|
-
| 1,349,000 |
-
| | Others | 27,660,000 | 5,823,000 | 30,191,000 | 20,469,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,065,000 | (4,002,000) | (16,859,000) | (9,741,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 300,000 | (300,000) |
-
| 672,000 | | Earnings Before Interest And Taxes | 6,365,000 | (4,302,000) | (16,867,000) | (9,061,000) | | Interest Expense | 5,782,000 | 6,486,000 | 7,952,000 | 8,263,000 | | Income Before Tax | 583,000 | (10,788,000) | (24,819,000) | (17,324,000) | | Income Tax Expense | (184,000) | (937,000) | (967,000) | 7,971,000 | | Minority Interest |
-
|
-
| (8,000) | 8,000 | | | | Net Income From Continuing Ops | 767,000 | (9,851,000) | (23,852,000) | (25,295,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 767,000 | (9,851,000) | (23,852,000) | (25,295,000) | | Preferred Stock And Other Adjustments | (1,141,000) | (378,000) | (166,000) | (6,000) | | | Net Income Applicable To Common Shares | ($374,000) | ($10,229,000) | ($24,018,000) | ($25,301,000) |
|
2.03% Nasdaq 0.00%
Income Statement
